New Dosage Imitrex® STATdose Now Available
December 28, 1992, marked a new era for Migraine and cluster headaches sufferers when the FDA approved the first of a class of medications that many would come to call "miracle drugs." That drug was the injectable form of sumatriptan (Imitrex®, Imigran®), the first of the triptans. Now, the FDA has approved a new Imitrex® STATdose in a 4mg dosage. This is the same STATdose injection system patients have been using; only the dosage has changed. The 4mg STATdose provides a new option to patients for whom the 6mg was "too strong" or may have produced uncomfortable side effects. Feature article.
Living Well with Migraine Disease and Headaches: What Your Doctor Doesn't Tell You... That You Need To Know rose to the top rankings of books on headaches and Migraine when it was released on November 1 and has remained there since.
Another medication can now be added to the growing list of medications shown to be effective for prevention of headaches and Migraine attacks. Namenda (memantine HCL, Forest Pharmaceuticals) was approved for use in the United States in October, 2003, more than a decade after its use began in Europe under the brand names Ebixa and Axura. It's classified as an orally active NMDA receptor antagonist. Namenda (memantine hydrochloride) is approved for the treatment of "moderate to severe dementia of the Alzheimer's type."
Yesterday,